CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO & President bought 100,000 shares at $9.11 ($911,000)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CEO & President sold 4,060 shares at $13.35 ($54,201)
- 4 Planned sale Chief Medical Officer sold 1,342 shares at $13.35 ($17,916)
- 4 Planned sale Chief Commercial Officer sold 146 shares at $13.35 ($1,949)
Page 11 of 40 · 796 filings